REPRIEVE-Logo-WebREPRIEVE-Logo-WebREPRIEVE-Logo-WebREPRIEVE-Logo-Web
  • About REPRIEVE
    • Our Story
    • Publications
    • In the News
    • Study FAQ
    • REPRIEVE @ CROI 2023
  • Meet Our Team
    • Clinical Coordinating Center (CCC)
    • Data Coordinating Center (DCC)
    • REPRIEVE Site Teams
    • Community Scientific Subcommittee (CSS)
    • REPRIEVE Community Advisory Board (CAB)
    • National Institutes of Health
  • For Participants
    • Meet REPRIEVE Participants
    • My Matters Blog
    • Participant Newsletter
    • REPRIEVE Community Forum
    • Recursos en Español
      • Preguntas Más Frecuentes
      • Mapa de Centros de Investigación Clínica
      • Gacetilla Para Participantes N° 1
  • Our Sites
  • Site Resources
    • REPRIEVE Site Newsletters
    • REPRIEVE Retention Toolkit
  • My Matters Blog
  • Contact Us
✕

For Participants

  • REPRIEVE Community Advisory Board (CAB)

  • Meet REPRIEVE Participants

  • My Heart Matters Blog

  • Participant Newsletter

  • Recursos en Español

  • 2021 Community Forum

Search

✕
 

Recent News

  • INSTI Use Beyond Two Years Not Associated With Greater Weight Gain in Global REPRIEVE Study
    March 20, 2023
  • New insights into how patient factors and COVID-19 infection affect antibody responses in people with HIV
    March 13, 2023
©2019 | This website, and any related materials applies only to REPRIEVE A5332. See list of participating sites here.